NO20005681L - Nye formuleringer som inneholder paroxetin - Google Patents

Nye formuleringer som inneholder paroxetin

Info

Publication number
NO20005681L
NO20005681L NO20005681A NO20005681A NO20005681L NO 20005681 L NO20005681 L NO 20005681L NO 20005681 A NO20005681 A NO 20005681A NO 20005681 A NO20005681 A NO 20005681A NO 20005681 L NO20005681 L NO 20005681L
Authority
NO
Norway
Prior art keywords
formulations containing
new formulations
containing paroxetine
paroxetine
hemihydrate
Prior art date
Application number
NO20005681A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005681D0 (no
Inventor
David Philip Elder
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20005681D0 publication Critical patent/NO20005681D0/no
Publication of NO20005681L publication Critical patent/NO20005681L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20005681A 1998-05-13 2000-11-10 Nye formuleringer som inneholder paroxetin NO20005681L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810180.1A GB9810180D0 (en) 1998-05-13 1998-05-13 Novel formulation
PCT/GB1999/001522 WO1999058116A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (2)

Publication Number Publication Date
NO20005681D0 NO20005681D0 (no) 2000-11-10
NO20005681L true NO20005681L (no) 2000-12-01

Family

ID=10831926

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005681A NO20005681L (no) 1998-05-13 2000-11-10 Nye formuleringer som inneholder paroxetin

Country Status (20)

Country Link
EP (1) EP1077685A2 (id)
JP (1) JP2002514593A (id)
KR (1) KR20010043545A (id)
CN (1) CN1309557A (id)
AP (1) AP2000001985A0 (id)
AU (1) AU3941099A (id)
BG (1) BG105011A (id)
BR (1) BR9910402A (id)
CA (1) CA2331849A1 (id)
EA (1) EA200001173A1 (id)
GB (1) GB9810180D0 (id)
HU (1) HUP0101931A3 (id)
ID (1) ID27018A (id)
IL (1) IL139596A0 (id)
NO (1) NO20005681L (id)
PL (1) PL344872A1 (id)
SK (1) SK16972000A3 (id)
TR (1) TR200003351T2 (id)
WO (1) WO1999058116A2 (id)
ZA (1) ZA200006465B (id)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE311883T1 (de) 1999-03-12 2005-12-15 Aesica Pharmaceuticals Ltd Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
WO2013145750A1 (ja) * 2012-03-29 2013-10-03 杏林製薬株式会社 カプセル製剤
DE102013207447A1 (de) 2013-04-24 2014-10-30 Evonik Degussa Gmbh Verfahren und Vorrichtung zur Herstellung von Octachlortrisilan
CN103520131B (zh) * 2013-10-12 2019-05-14 浙江华海药业股份有限公司 盐酸帕罗西汀半水合物胶囊的制备方法
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031197A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation

Also Published As

Publication number Publication date
CA2331849A1 (en) 1999-11-18
ID27018A (id) 2001-02-22
HUP0101931A2 (hu) 2002-04-29
CN1309557A (zh) 2001-08-22
PL344872A1 (en) 2001-11-19
AU3941099A (en) 1999-11-29
WO1999058116A2 (en) 1999-11-18
HUP0101931A3 (en) 2002-10-28
SK16972000A3 (sk) 2001-06-11
BG105011A (en) 2001-07-31
GB9810180D0 (en) 1998-07-08
AP2000001985A0 (en) 2000-12-31
KR20010043545A (ko) 2001-05-25
NO20005681D0 (no) 2000-11-10
JP2002514593A (ja) 2002-05-21
EA200001173A1 (ru) 2001-04-23
BR9910402A (pt) 2001-01-09
TR200003351T2 (tr) 2001-03-21
EP1077685A2 (en) 2001-02-28
ZA200006465B (en) 2001-11-09
WO1999058116A3 (en) 2000-02-17
IL139596A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
EA199800140A1 (ru) Композиции с контролируемым высвобождением пароксетина
HUP9903741A2 (hu) Asztmaellenes, allergiaellenes, immunvisszaszorító és/vagy immunmoduláló hatású N-helyettesített indol-3-glioxilamidok
ES2137549T3 (es) Derivados antifungicos de sordaridina.
DE60019334D1 (de) Antivirale arznei
EA200400455A1 (ru) Способ приготовления быстрорастворимой дозировочной формы
DE50105771D1 (de) Ibuprofen-wirkstoffzubereitung
EA200500213A1 (ru) Диспергируемые таблетки для орального назначения
DK1105105T3 (da) Oral administrationsform til pyridin-2-ylmethylsulfinyl-1H-benzimidazoler
GEP20063972B (en) Streptogramin derivatives, preparation and compositions containing them
YU45395A (sh) Novo hemijsko jedinjenje, njegovo pripremanje i njegova primena kao leka
MEP5808A (xx) Ecitalopram bromhidrat i postupak za njegovo pripremanje
DK0755919T3 (da) Substituerede kanelsyreguanidider, fremgangsmåde til deres fremstilling, deres anvendelse som hjerte-kredsløbs-medikament e
NO20004919D0 (no) FremgangsmÕte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater
NO20005683L (no) Ny formulering inneholdende paroxetin
AP2000001985A0 (en) Novel formulation containing paroxetine.
PL356523A1 (en) Substituted 1 and 2 naphthol mannich bases
NO971851L (no) Barnesikker forpakning for virkestoffinneholdende plaster
SE0000055D0 (sv) Novel process
NO20000199L (no) Medikamenter inneholdende polyhydroksybutylpyraziner, nye polyhydroksybutylpyraziner og deres fremstilling
DK1157020T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-2-benzazocin-10-oler, fremgangsmåder til deres fremstilling og deres anvendelse som lægemiddel
HUT77439A (hu) Új eljárás ranitidin előállítására
ATE243695T1 (de) 5-bicycloindolverbindungen
AU1022201A (en) Novel LTB4 antagonist, method for the production thereof and its use as a medicament
FI851335A7 (fi) Uudet substituoidut bentsodioksolijohdannaiset, menetelmä niiden valmistamiseksi ja vastaavat farmaseuttiset koostumukset.
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application